- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Total 157718 results
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruitingNon-Small Cell Lung Cancer | Lung CancerUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Netherlands, Spain, Belgium, Brazil, Japan, China, Australia, Germany, Argentina, Canada, Czechia, France
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNon-small Cell Lung CancerUnited States
-
Scholar Rock, Inc.Active, not recruitingCancerUnited States, Korea, Republic of
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedLymphoma | Metastatic Melanoma | Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm and other conditionsUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedNon-Squamous Non-Small Cell Lung CancerChina
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerCanada, Belgium, Brazil, China, Denmark, Portugal, Spain, United Kingdom, Argentina, Bulgaria, Colombia, Germany, India, Ireland, Italy, Luxembourg, Mexico, Poland, Romania, Slovakia, Switzerland, Vietnam, Kazakhstan, Czechia
-
AstraZenecaCompletedNon-small Cell Lung Cancer (NSCLC)United Kingdom, United States, Italy, Spain, Germany, France
-
National Cancer Institute (NCI)Active, not recruitingHIV Infection | Hepatocellular Carcinoma | Non-Hodgkin Lymphoma | Metastatic Lung Non-Small Cell Carcinoma | Metastatic Melanoma | Kaposi Sarcoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Locally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable... and other conditionsUnited States
-
AstraZenecaCompletedLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Poland, France, Germany, Brazil, Hungary, Netherlands, Bulgaria
-
Betta Pharmaceuticals Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer | EGFR Gene MutationChina
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
Massachusetts General HospitalConquer Cancer FoundationActive, not recruitingStage IV Non-Small Cell Lung Cancer | Stage IV Bladder Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Immunotherapy | Immune Checkpoint Inhibitors | Stage IV Gastric Cancer | Stage IV Merkel Cell Carcinoma | Stage IV Colorectal Cancer | Stage IV Esophageal Cancer | Advanced Lung Cancer | Stage IV Renal... and other conditionsUnited States
-
Mario Negri Institute for Pharmacological ResearchAstraZeneca; Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoActive, not recruitingNon-small Cell Lung Cancer Stage IIIItaly, Spain, France
-
Groupe Français de Pneumo-CancérologieAstraZenecaActive, not recruitingNon-Small Cell Lung CancerFrance
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Argentina, India, Taiwan, Thailand, Vietnam
-
University of OxfordCancer Research UK; Guy's and St Thomas' NHS Foundation Trust; NHS Lothian; National... and other collaboratorsCompletedLocally Advanced Non-Small Cell Lung CancerUnited Kingdom
-
Latin American Cooperative Oncology GroupAstraZeneca; Libbs Farmacêutica LTDAActive, not recruiting
-
AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited Kingdom
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
AstraZenecaActive, not recruitingAnticancer TreatmentUnited States, France, Germany, Spain, Sweden, United Kingdom, Canada, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, China, Taiwan, Hong Kong, Netherlands, Australia, Mexico
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
AstraZenecaCompletedNon-small Cell Lung CancerCanada
-
Hoffmann-La RocheCompletedNon-Small Cell Lung Cancer (NSCLC)Germany
-
University of Southern CaliforniaNational Cancer Institute (NCI); Vasgene Therapeutics, IncTerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Pancreatic Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage... and other conditionsUnited States
-
Shanghai Henlius BiotechActive, not recruitingSquamous Non Small Cell Lung CancerChina, Turkey, United States, Georgia, Poland, Russian Federation, Ukraine
-
Shanghai Henlius BiotechActive, not recruitingLocally Advanced or Metastatic Solid Tumors | Squamous-cell Non-small Cell Lung CancerChina
-
M.D. Anderson Cancer CenterTerminatedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIC Lung Cancer AJCC v8 | Unresectable Lung... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Unresectable Head and Neck Squamous Cell Carcinoma | Unresectable Oropharyngeal... and other conditionsUnited States
-
ExelixisActive, not recruitingRenal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Urothelial Carcinoma | Differentiated Thyroid Cancer | Gastroesophageal... and other conditionsUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Novartis PharmaceuticalsWithdrawn
-
Albert Einstein College of MedicineActive, not recruitingNon-small Cell Lung CancerUnited States
-
AstraZenecaTerminatedUnresectable Stage III NSCLCUnited States
-
Novartis PharmaceuticalsCompletedLocally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 MutationsGermany
-
Nektar TherapeuticsTerminatedNon-Small Cell Lung CancerUnited States, Germany, Spain, Australia, France
-
Kura Oncology, Inc.Withdrawn
-
Bristol-Myers SquibbActive, not recruiting
-
Sihuan Pharmaceutical Holdings Group Ltd.TerminatedNon Small Cell Lung CancerChina
-
Daiichi Sankyo Co., Ltd.TerminatedNon Small Cell Lung CancerJapan
-
CelgeneCompletedDiffuse Large B-Cell Lymphoma | Multiple Myeloma | Hepatocellular Carcinoma | Non-Small Cell Lung Cancer | Glioblastoma Multiforme | Neuroendocrine Tumors of Non-Pancreatic Origin | Hormone Receptor-Positive Breast CancerUnited States, Spain, United Kingdom, France
-
Albert Einstein College of MedicineMontefiore Medical CenterActive, not recruitingNon-small Cell Lung Cancer, NSCLCUnited States
-
Guangdong Provincial People's HospitalCompletedChemotherapy | Non Small Cell Lung Cancer | Immunotherapy | Tumour, ResidualChina
-
Sun Yat-sen UniversityWithdrawnEfficacy and Safety | Locally Advanced Non-small Cell Lung CancerChina
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerSpain, Taiwan, Korea, Republic of, Singapore, China, Malaysia, Italy
-
PfizerCompletedAdvanced Non-Small Cell Lung CancerIndia
-
Hoffmann-La RocheCompleted
-
Jianguo SunCompletedStage III Non-small-cell Lung Cancer